1. Home
  2. CLWT vs AIM Comparison

CLWT vs AIM Comparison

Compare CLWT & AIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLWT
  • AIM
  • Stock Information
  • Founded
  • CLWT 1971
  • AIM 1966
  • Country
  • CLWT Hong Kong
  • AIM United States
  • Employees
  • CLWT N/A
  • AIM N/A
  • Industry
  • CLWT Professional and commerical equipment
  • AIM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CLWT Consumer Discretionary
  • AIM Health Care
  • Exchange
  • CLWT Nasdaq
  • AIM Nasdaq
  • Market Cap
  • CLWT 8.9M
  • AIM 8.8M
  • IPO Year
  • CLWT 1997
  • AIM N/A
  • Fundamental
  • Price
  • CLWT $1.19
  • AIM $0.13
  • Analyst Decision
  • CLWT
  • AIM Strong Buy
  • Analyst Count
  • CLWT 0
  • AIM 2
  • Target Price
  • CLWT N/A
  • AIM $2.75
  • AVG Volume (30 Days)
  • CLWT 10.5K
  • AIM 525.3K
  • Earning Date
  • CLWT 04-29-2025
  • AIM 03-27-2025
  • Dividend Yield
  • CLWT 6.72%
  • AIM N/A
  • EPS Growth
  • CLWT 630.02
  • AIM N/A
  • EPS
  • CLWT 0.28
  • AIM N/A
  • Revenue
  • CLWT $17,242,000.00
  • AIM $170,000.00
  • Revenue This Year
  • CLWT N/A
  • AIM N/A
  • Revenue Next Year
  • CLWT N/A
  • AIM $1,693.10
  • P/E Ratio
  • CLWT $3.96
  • AIM N/A
  • Revenue Growth
  • CLWT 6.59
  • AIM N/A
  • 52 Week Low
  • CLWT $1.08
  • AIM $0.11
  • 52 Week High
  • CLWT $1.94
  • AIM $0.62
  • Technical
  • Relative Strength Index (RSI)
  • CLWT 33.78
  • AIM 43.86
  • Support Level
  • CLWT $1.18
  • AIM $0.11
  • Resistance Level
  • CLWT $1.25
  • AIM $0.16
  • Average True Range (ATR)
  • CLWT 0.07
  • AIM 0.01
  • MACD
  • CLWT -0.02
  • AIM 0.00
  • Stochastic Oscillator
  • CLWT 0.00
  • AIM 25.00

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.

About AIM AIM ImmunoTech Inc.

AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders and viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases, and the drug Alferon N Injection for a category of STD infection. Clinical trials of Ampligen include studies of cancer patients with renal cell carcinoma, malignant melanoma, colorectal cancer, advanced recurrent ovarian cancer, and triple-negative metastatic breast cancer. It is also advancing Ampligen as a potential treatment for COVID-19. FDA has authorized the first human trial assessing the safety and effectiveness of Ampligen in combination with interferon alfa-2b, in cancer patients with COVID-19.

Share on Social Networks: